Short-term effects of thyroid hormones on cytoskeletal proteins are mediated by GABAergic mechanisms in slices of cerebral cortex from young rats.
: Thyroid hormones play important roles in brain function. However, few information is available about the effect of 3,5,3'-triiodo-L-thyronine (T(3)) or thyroxine (T(4)) on the in vitro phosphorylation of intermediate filament (IF) proteins from cerebral cortex of rats. In this study we investigated the involvement of GABAergic mechanisms mediating the effects of T(3) and T(4) on the in vitro incorporation of (32)P into IF proteins from cerebral cortex of 10-day-old male rats. Tissue slices were incubated with or without T(3), T(4), gamma-aminobutiric acid (GABA), kinase inhibitors or specific GABA antagonists and (32)P-orthophosphate for 30 min. The IF-enriched cytoskeletal fraction was extracted in a high salt Triton-containing buffer and the in vitro (32)P incorporation into IF proteins was measured. We first observed that 1 microM T(3) and 0.1 microM T(4) significantly increased the in vitro incorporation of (32)P into the IF proteins studied through the PKA and PKCaMII activities. A similar effect on IF phosphorylation was achieved by incubating cortical slices with GABA. Furthermore, by using specific GABA antagonists, we verified that T(3) induced a stimulatory effect on IF phosphorylation through noncompetitive mechanisms involving GABA(A), beyond GABA(B) receptors. In contrast, T(4) effects were mediated mainly by GABA(B) mechanisms. In conclusion, our results demonstrate a rapid nongenomic action of T(3) and T(4) on the phosphorylating system associated to the IF proteins in slices of cerebral cortex of 10 day-old male rats and point to GABAergic mechanisms mediating such effects.
Zamoner
Ariane
A
Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, UFRGS, Porto Alegre, RS, Brazil.
Funchal
Cláudia
C
Heimfarth
Luana
L
Silva
Fátima R M B
FR
Pessoa-Pureur
Regina
R
D000818:Animals; D002540:Cerebral Cortex / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D003598:Cytoskeletal Proteins / Q000378:metabolism*; D003599:Cytoskeleton / Q000187:drug effects* / Q000378:metabolism; D007382:Intermediate Filaments / Q000378:metabolism*; D008297:Male; D021122:Protein Subunits / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D013974:Thyroxine / Q000494:pharmacology*; D014284:Triiodothyronine / Q000494:pharmacology*; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*
D003598:Cytoskeletal Proteins; D021122:Protein Subunits; D014284:Triiodothyronine; D005680:gamma-Aminobutyric Acid; D013974:Thyroxine